American Homes 4 Rent Class A (AMH) Stock Price Today
Aura AI Summary
Key Stats
- $11.26BMarket Cap
- 3,129,770Volume
- Real EstateSector
- $34.8152W High
- $27.3852W Low
- 81 DaysTypical Hold Time
- $16.32BEnterprise Value
- 4.22%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track American Homes 4 Rent Class A (AMH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, American Homes 4 Rent Class A has traded between a low of $27.38 and a high of $34.81, highlighting its annual price range. Buy and sell American Homes 4 Rent Class A shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About American Homes 4 Rent Class A
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Most Recent News
Chery Auto unveils L4 Robotaxi and partners with UAE's K2 for global commercial launch
Chery Auto will showcase its purpose-built Level 4 (L4) Robotaxi at the 2026 Chery International User Summit and sign a strategic cooperation agreement with UAE-based K2. The Robotaxi offers a fully driverless passenger experience from booking to rid...

AiMOGA launches Mobo, a home companion humanoid robot, with global pre-orders opening at Chery 2026 summit
AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Mobo uses advanced AI to understand complex commands, navigate home environments, and remem...

EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia
Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.